- Home
- ATAI vs BCAT Comparison
ATAI vs BCAT Comparison
Compare ATAI & BCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATAI | BCAT |
|---|---|---|
| Founded | 2018 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2025 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ATAI | BCAT |
|---|---|---|
| Price | $4.94 | $15.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $15.88 | N/A |
| AVG Volume (30 Days) | ★ 10.1M | 610.1K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.38% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,089,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.22 |
| Revenue Growth | ★ 1227.60 | N/A |
| 52 Week Low | $2.58 | $13.73 |
| 52 Week High | $6.73 | $16.18 |
Technical Indicators
Market Signals| Indicator | ATAI | BCAT |
|---|---|---|
| Relative Strength Index (RSI) | 54.59 | 54.20 |
| Support Level | $3.56 | $15.50 |
| Resistance Level | $5.00 | $15.97 |
| Average True Range (ATR) | 0.43 | 0.19 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 62.50 | 63.49 |
Price Performance
Historical ComparisonAbout ATAI ATAI Life Sciences N.V.
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
About BCAT BlackRock Capital Allocation Term Trust of Beneficial Interest
BlackRock Capital Allocation Trust is a non-diversified, closed-end management investment company. The investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation.